Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, and Fertin Pharma A/S (www.fertin.com), a world leader in the development and manufacture of medicinal chewing gum, jointly announced today that they have established a collaboration for the development of a metformin medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity.
